PCN103 PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FLUDARABINE-CYCLOPHOSPHAMIDE REGIMEN IN THE FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS IN SPAIN
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74354-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)74354-0/fulltext
Title :
PCN103 PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FLUDARABINE-CYCLOPHOSPHAMIDE REGIMEN IN THE FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74354-0&doi=10.1016/S1098-3015(10)74354-0
First page :
Section Title :
Open access? :
No
Section Order :
278